Pharma companies are discovering that developing apps and digital health technologies is just like developing drugs--at least when it comes to persuading…

Right now, GlaxoSmithKline’s meningitis B vaccine, Bexsero, doesn’t have the key “universal use” endorsement the company wants from the CDC. So it’s spreading…

India’s Sun Pharma has had a host of problems at some of its own manufacturing facilities in India but it just narrowly escaped another warning letter for a…

Pharma ads may be ubiquitous during prime-time TV, but during the Olympic Games in Rio? Not so much. With $1.18 billion spent overall, pharma only accounted…

The Attorney General in New York and some patients have filed suits against insurers that have balked at covering expensive hepatitis C drugs, while Medicaid…

Dublin-based Mallinckrodt company has decided it needs a U.S. campus to consolidate workers picked up in an M&A spree, as well as some more manufacturing,…

Mylan is facing the prospect of investigations--as well as public criticism--following years of price increases on its big-selling EpiPen.

When one M&A door closes, many windows open. After Pfizer wrapped up a $14B Medivation buy Monday, investors bid up BioMarin, Incyte and more as likely…